Critical urgency
-Very severe
It is an infectious disease caused by the Ebola virus. It is highly virulent, with a mortality rate close to 60%. It is only transmitted by sick people (not carriers) via contact with body secretions, blood or implanted tissue. It manifests with high fever and muscle pain, headache, pain when swallowing, vomiting and/or bleeding. It is suspected if there has been previous contact with people in endemic areas (Liberia, Sierra Leone, Guinea-Conakry, and Nigeria). It is confirmed by laboratory tests. There is no specific treatment. It is always urgent to seek a consultation when infection and fever are suspected.
- Mike Bray, Daniel S Chertow. Epidemiology and pathogenesis of Ebola virus disease. UpToDate. Apr 12, 2016.
- Mike Bray, Daniel S Chertow. Clinical manifestations and diagnosis of Ebola virus disease. UpToDate. Apr 28, 2016.
- Mike Bray, Daniel S Chertow. Treatment and prevention of Ebola virus disease. UpToDate. Oct 25, 2016.
- Uyeki TM, Mehta AK, Davey RT Jr, et al. Clinical Management of Ebola Virus Disease in the United States and Europe. N Engl J Med 2016; 374:636.
- WHO Ebola Response Team. Ebola Virus Disease among Male and Female Persons in West Africa. N Engl J Med 2016; 374:96.
- Dean NE, Halloran ME, Yang Y, Longini IM. Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection. Clin Infect Dis 2016; 62:1277.
- Janvier F, Foissaud V, Cotte J, et al. Monitoring of Prognostic Laboratory Markers in Ebola Virus Disease. J Infect Dis 2016; 213:1049.
- Ministerio de Sanidad, Servicios Sociales e Igualdad. INFORMACIÓN SOBRE EL BROTE DE ENFERMEDAD POR VIRUS ÉBOLA (EVE). Last accessed: Feb 15, 2017 https://www.msssi.gob.es/profesionales/saludPublica/ccayes/alertasActual/ebola/infProfesionales.htm
Dr. Sara Vitoria
Copyright© TeckelMedical 2026
